<i>Bifidobacterium lactis</i> BB-12 Attenuates Macrophage Aging Induced by D-Galactose and Promotes M2 Macrophage Polarization

Zhang, Da-yong; Pan, Zheng-yang; Yu, Xiong-kai; Chen, Yi-fan; Gao, Chen-hao; Yang, Yu-tian; Jiang, Xue-fan; Li, Na; Pan, Jian-ping

doi:https://doi.org/10.1155/2019/4657928

Journal of Immunology Research

On this page

Abstract Introduction Methods and Materials Results Discussion Conclusion Data Availability Conflicts of Interest Authors’ Contributions Acknowledgments Supplementary Materials References Copyright Related Articles

Research Article | Open Access

Volume 2019 | Article ID 4657928 | https://doi.org/10.1155/2019/4657928

Bifidobacterium lactis BB-12 Attenuates Macrophage Aging Induced by D-Galactose and Promotes M2 Macrophage Polarization

Da-yong Zhang,¹Zheng-yang Pan,¹Xiong-kai Yu,¹Yi-fan Chen,¹Chen-hao Gao,¹Yu-tian Yang,¹Xue-fan Jiang,^2,3Na Li,¹and Jian-ping Pan¹

Academic Editor: Enrique Ortega

Received28 Jan 2019

Revised10 Oct 2019

Accepted14 Nov 2019

Published19 Dec 2019

Abstract

Immunosenescence comprises a set of dynamic changes occurring in innate and adaptive immune systems, and macrophage aging plays an important role in innate and adaptive immunosenescence. However, function and polarization changes in aging macrophages have not been fully evaluated, and no effective method for delaying macrophage senescence is currently available. The results of this study reveal that D-galactose (D-gal) can promote J774A.1 macrophage senescence and induce macrophage M1 polarization differentiation. Bifidobacterium lactis BB-12 can significantly inhibit J774A.1 macrophage senescence induced by D-gal. IL-6 and IL-12 levels in the BB-12 groups remarkably decreased compared with that in the D-gal group, and the M2 marker, IL-10, and Arg-1 mRNA levels increased in the BB-12 group. BB-12 inhibited the expression of p-signal transducer and activator of transcription 1 (STAT1) and promoted p-STAT6 expression. In summary, the present study indicates that BB-12 can attenuate the J774A.1 macrophage senescence and induce M2 macrophage polarization, thereby indicating the potential of BB-12 to slow down immunosenescence and inflamm-aging.

1. Introduction

As we age, changes in essentially all physiological functions, including immunity, become apparent [1]. Immunosenescence is the state of dysregulated immune function that contributes to the increased incidence of different chronic diseases, such as infections, autoimmune disorders, chronic inflammatory diseases, and cancer [2, 3]. Macrophage, which is one of the important immune cells, plays a pivotal role in the regulation of the innate and acquired immune responses [4]. However, the present study showed that macrophages also experience changes due to aging and have an immense influence on immunosenescence [5]. The quantity of aging-related galactosidase- (SA-β-gal-) positive macrophages in the senescence accelerated-prone mice (SAPM8) is considerably larger than that in young mice, and CD36 expression levels and IL-10 level decrease in aging macrophages [6]. Downregulated p16 (an aging promoting factor) can significantly delay macrophage aging and upregulate Arg-1 [7], MRC1, and AMAC1 expression levels [8]. These results indicated that macrophages also undergo changes due to aging, and functional change in aging macrophages may be an important constituent part of immunosenescence and inflamm-aging. However, the study of aging macrophage is still insufficient, and a stable, simple, and convenient in vitro induction method for macrophage aging remains unavailable. D-Galactose (D-gal) is a ROS accelerant that is a common reagent used to build an aging animal model. Our group [9, 10] and another research group [11] have found that D-gal is also a favorable inducer for the cell aging model in in vitro research. Therefore, in the present study, the influence of D-gal on macrophage aging and polarization was observed first.

As a representative of intestinal probiotics, Bifidobacterium is widely used in nutritional supplements, has multiple physiological activities, and facilitates an organism’s health [12]. However, the quantity of Bifidobacteria in aging individuals considerably decreases due to weakened intestinal barrier function, decreased gastric acid secretion, and reduced immunologic functions with age [13–15]. The quantity of intestinal Bifidobacteria in healthy longevity of older people in Bama County is considerably higher than that of normal people [16]. The lipoteichoic acid in Bifidobacterium can also delay cell senescence [17]. Hence, Bifidobacterium has a positive influence on an organism or cellular aging. Bifidobacterium BB-12 (BB-12) is a catalase-negative, rod-shaped Bifidobacterium derived from animals. BB-12 was deposited in the cell culture bank of Chr. Hansen in 1983, and one of Bifidobacterium spp. has been studied and commercially used to the greatest extent [18]. At present, BB-12 is classified as Bifidobacterium animalis subsp. lactis. BB-12 can exert multiple health-promoting effects on an organism [19, 20] and is beneficial to immune function [21–23]. Bifidobacterium supernatant contains a variety of active substances, including polysaccharides [24], proteins [25], and fatty acids [26]. These ingredients have antioxidation, immune regulation, and other antiaging effects [25, 27, 28]. Bifidobacterium supernatant can also reverse D-gal-induced organ aging and decrease memory in aging rats [29]. However, the role of BB-12 on cellular aging is still poorly understood. In the present study, the effects of BB-12 supernatant on D-gal-induced macrophage aging were observed for the first time. This observation provided fundamental experimental data regarding effective methods for delaying macrophage aging through the application of Bifidobacterium.

Heterogeneity and functional plasticity are two of the most important characteristics of macrophages. Under the effects of different stimulants (pathogenic microorganism products, damaged cells, and activated lymphocytes) in the cellular microenvironment, macrophages can be polarized into two major types, that is, classically (M1 macrophage) and alternatively activated macrophages (M2 macrophage) [30, 31]. The sterilizing functions of M1 macrophages, productions of proinflammatory factors (IL-6, IL-12, etc.), and complement-mediated phagocytic functions can be significantly upregulated to exert the anti-infection effect [32]. M2 macrophages secrete anti-inflammatory cytokines (e.g., IL-4 and IL-10) and exert effects on tissue repair and reconstruction processes [33]. The study showed that M1 macrophage levels in mice increase with age, and this increase is related to the declined damage repair ability of aging mice and long-term maintenance of an inflammation state [34]. The expression levels of macrophage M2 polarization marker IL-10 in SAPM8 mice decreased [6], and delaying microphage aging can upregulate the expression level of macrophage M2 polarization marker Arg-1 [7]. These results indicated that after macrophage aging, they can be differentiated into proinflammatory M1 state. Thus, macrophage aging may be closely related to the fact that multiple organs in aging individual are under chronic and sustainable inflammation state for a long time, which is also called inflamm-aging. In the present study, the effects of BB-12 on macrophage polarity and aging were further observed. The molecular mechanisms that determine M1 or M2 polarization involve specific transcription factors, such as signal transducer and activator of transcription 1 (STAT1), which is a critical transcription factor and results in M1 polarization [35, 36]. Meanwhile, STAT6 is an essential protein in activating M2 macrophage and regulating the balance of inflammatory response [37]. STAT1 or STAT6 is also closely linked to elderly degenerative diseases and immunosenescence. In Alzheimer’s disease, STAT1 and senescence-related protein p53 are considerably upregulated in microglia [38]. Impaired actin filament dynamics, which is a common phenomenon in cellular senescence and degenerative glial cells, can reduce phospho-STAT6 levels in microglia [39]. Therefore, to explore the mechanisms of BB-12 regulating the polarity of macrophages, we further examined the effects of BB-12 on the phosphorylation of STAT1/STAT6 in macrophages.

Immunosenescence is an important factor influencing organism aging. In this study, D-gal was utilized to construct an in vitro macrophage aging research model, the influences of BB-12 on macrophage aging and polarity were examined, and its molecular mechanism was explored.

2. Methods and Materials

2.1. Bacterial Culture and Bifidobacterium Supernatants

Bifidobacterium animalis subsp. lactis BB-12 were purchased from Chr. Hansen, Denmark. BB-12 was incubated in bacteria culture medium (MRS) broth (Difco, Detroit, MI, USA) supplemented with 5% () galactose in the anaerobic conditions at 37°C for 24 h, followed by dilution in the MRS broth and incubation to reach the exponential phase with the density of 0.5 at an optical density (OD) of 600 nm. The culture suspensions were centrifuged at for 10 min at 4°C, then filter-sterilized through 0.22 μm filters. Finally, the supernatant was standardized to 10 μg of protein/μL using the BCA protein assay kit (Beyotime, China).

2.2. J774A.1 Cell Culture and Treatment

Mouse monocyte-macrophage cells (J774A.1) were obtained from the Shanghai Institute of Cell Biology at Chinese Academy of Sciences. The cells were cultured and maintained in Roswell Park Memorial Institute (RPMI-1640) supplemented with streptomycin (100 mg/mL), penicillin (100 U/mL), and 10% fetal bovine serum (FBS) in a 5% CO₂ incubator at a temperature of 37°C. Then, J774A.1 cells were divided into the following groups: (1) Control group: macrophages were cultured for 24 h in RPMI-1640 containing 10% FBS. (2) D-gal treatment groups: J774A.1 cells were incubated for 24 h in RPMI-1640 containing 10% FBS in the presence of 0.1, 1, or 10 g/L D-gal (Sigma, USA), respectively. (3) BB-12 treatment groups: briefly, J774A.1 cells were treated with the BB-12 supernatant (100 μg/mL) in RPMI-1640 containing 10% FBS for 30 min,1 h, or 6 h, then culture medium were changed, and the cells were further cultured in RPMI-1640 containing 10% FBS in the presence 10 g/L D-gal for 24 h.

2.3. SA-β-Gal Staining

Senescence-associated β-galactosidase (SA-β-gal) staining was performed using a SA-β-gal staining kit (Beyotime, China) following the manufacturer’s protocol. The treatment methods for the J774A.1 in each group were the same as described above. The cells were fixed in 4% () formaldehyde for 5 min and then were stained with SA-β-gal staining solution at pH 6.0 for 24 h. The SA-β-gal-positive cells exhibited a blue color. The number of positive cells was counted under a phase-contrast microscope. The experiment was repeated five times in each group.

2.4. ROS Staining

ROS staining was performed using an ROS staining kit (Beyotime, China) following the manufacturer’s protocol. After each group was cultured according to the above treatment methods, the cells were washed three times in PBS and incubated in ROS staining solution (DCFH-DA) at 37°C for 20 min. After washing, the nuclei were counterstained with Hoechst 33342 (Sigma, USA). The cells were observed using a fluorescence microscope. To quantify the ROS level, the DCFH fluorescence intensity in the cells was detected by a flow cytometer (Calibur, BD Biosciences, USA) at an excitation wavelength of 488 nm and an emission wavelength of 525 nm. Experiments were repeated three times.

2.5. Detection of Cytokines by Enzyme-Linked Immunosorbent Assay (ELISA)

The J774A.1 macrophages were cultured as described above. Supernatants of J774A.1 cell culture were collected after 6 h of incubation. Concentrations of IL-6, IL-12, and IL-10 were determined by ELISA according to the manufacturer’s instructions (Peprotech, Mexico) in triplicate wells for all individual treatments.

2.6. Detection of Cell Viability by the Cell Counting Kit -8 (CCK-8)

The J774A.1 macrophages were plated and treated as described above in 96-well plates (three wells per group). Approximately 10 μL of CCK-8 (Dojindo, Japan) was added to the culture medium, and the OD value of the cells was measured at 450 nm using an ELISA reader (Thermo Multiskan GO, USA) according to the manufacturer’s instructions. The experiment was repeated 3 times, and the average values were obtained.

2.7. RNA Extraction and Quantitative Real-Time PCR (qPCR)

RNA was isolated from J774A.1 macrophages using TRIzol according to the manufacturer’s recommendation (Invitrogen, USA). The RNA was quantified, and its quality was assessed by agarose gel electrophoresis and absorbance measurements at λ260/λ280 nm with the Nanodrop ND-1000 spectrophotometer. First-strand cDNA was synthesized using RevertAid first strand cDNA synthesis kit (Takara, Japan), according to the manufacturer’s protocol. The reverse transcription reactions were performed at 25°C for 5 min, followed by 42°C for 60 min and 70°C for 5 min. The cDNAs were stored at −80°C for later use. qPCR was performed using a CFX-96 Real-time PCR Detection System (Bio-Rad, USA). SYBR Green Master Mix (Bio-Rad, USA) was used to examine relative gene expression. Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) was used to normalize the measured transcript, and the samples were run in triplicate. The relative quantity of gene expression was calculated automatically by the 2−ΔΔCq method. Primers were synthesized by Shanghai Shenggong Biology Engineering Technology Service, Ltd. (Shenggong, China), as follows: Arg-1 forward, 5-AGACCACAGTCTGGCAGTTG-3 and reverse, 5-CCACCCAAATGACACATAGG-3; GAPDH forward, 5-CTGCACCACCAACTGCTTAG-3 and reverse 5-GTCTGGGATGGAAATTGTGA-3.

2.8. Western Blot Analysis

To assay the expression of p53, p16, STAT1, STAT6, p-STAT1, and p-STAT6, the total cellular protein was extracted through the following methods: The different J774A.1 cell treatment groups were washed in cold-buffered PBS and were then lysed in RIPA buffer (150 mM NaCl, 1% Triton X-100, 0.5% NaDOD, 0.1% SDS, and 50 mM Tris, pH 8.0). After centrifugation (12,000 rpm, 5 min) at 4°C, the protein supernate was transferred into new tubes. The protein concentration of the samples was determined with a bicinchoninic acid protein assay (Pierce, USA). A 40-lg sample of the total protein was resolved using 12.5% SDS-PAGE and transferred onto polyvinylidene difluoride (PVDF, Millipore, USA) membranes. The membranes were blocked with 5% nonfat milk at room temperature for 1 h in Tris-buffered saline containing Tween 20 (TBST). Primary antibodies to detect p53 (1 : 1,000, BD, USA), p16 (1 : 1000, Santa Cruz, USA), STAT1 (1 : 1,000, CST, USA), STAT6 (1 : 1,000, CST, USA), p-STAT1 (Tyr701, 1 : 1,000, Thermo Fisher Scientific, USA), p-STAT6 (Thr645, 1 : 1,000, Thermo Fisher Scientific, USA), and β-actin (1 : 5000, BD, USA) were incubated overnight with the membranes at 4°C. Membranes were incubated with horseradish peroxidase- (HRP-) conjugated anti-rabbit secondary antibodies (1 : 2000, Dako, USA), and proteins were detected by enhanced chemiluminescence (ECL) (Amersham Biosciences Corp, USA). β-Actin was used as the internal control to normalize the loading materials. The p-STAT1 and p-STAT6 levels were quantified using ImageJ software (NIH, USA) and were expressed as the ratio after normalization to the total STAT1 and total STAT6.

2.9. Statistical Analysis

All experiments were performed at least in triplicate. All data are presented as the deviation of the mean (SD). Significance testing was performed using one-way analysis of variance (ANOVA) to compare data from different experimental groups, and multiple comparisons were made by Bonferroni’s test. For all analyses, A value < 0.05 was considered significant.

3. Results

3.1. D-Gal Promoted J774A.1 Macrophage Senescence

SA-β-gal staining was used to observe the effect of D-gal on J774A.1 macrophage senescence. After culturing in different D-gal concentrations (0.1, 1.0, or 10.0 g/L) for 24 h, the number of SA-β-gal-positive J774A.1 cells and the staining intensity of SA-β-gal increased (Figure 1(a)). The cell count revealed that the number of SA-β-gal-positive cells compared with that of the control group ( cells) significantly increased in the 1.0 and 10.0 g/L D-gal group ( and cells, ; Figure 1(b)). To evaluate the effects of D-gal on the macrophage senescence further, we harvested primary macrophages from the peritonium of Sprague-Dawley (SD) rats. The results of SA-β-gal staining showed that 1.0 or 10.0 g/L D-gal can induce primary macrophage senescence, and the number of SA-β-gal-positive cells in 1.0 and 10.0 g/L D-gal groups significantly increased compared with that in the control group (Figure S1).

(a)

(b)

(c)

Figure 1

Effects of D-gal on J774A.1 macrophage senescence. (a) SA-β-gal staining. With the increase in D-gal concentration, the number of SA-β-gal-positive cells increases in the 1 and 10 g/L D-gal group. . (b) SA-β-gal staining cell quantification. The total number of SA-β-gal-positive cells among 100 random cells was determined through phase-contrast microscopy. The results showed that the number of SA-β-gal-positive J774A.1 cells/100 cells in the 1.0 and 10.0 D-gal groups remarkably increased compared with that in the control group (, ). (c) Western blot analysis of p53 and p16 expression levels. The p53 and p16 expression levels were gradually higher in the 0.1, 1.0, and 10.0 g/L D-gal groups compared with those in the control group. β-Actin was used as the internal control.

The results of our previous study indicated that p53 and p16 were two important mediators of cellular senescence [40]. To explore the effect of D-gal on J774A.1 macrophage senescence, we examined the expression of senescence-related proteins p53 and p16 in J774A.1 macrophage. The Western blot results showed that with the increase in D-gal concentration, the p53 and p16 expression levels in the D-gal groups increased compared with those in the control group (Figure 1(c)). These results suggested that D-gal can induce macrophage senescence, and 10 g/L was a suitable D-gal-induced macrophage senescence concentration in vitro.

3.2. D-Gal Inhibited J774A.1 Macrophage Proliferation

Meanwhile, the cell proliferation was examined by CCK-8. The results indicated that J774A.1 macrophage proliferation can be inhibited by D-gal, and the absorbance values in 1.0 and 10.0 g/L D-gal groups ( and ) significantly decreased compared with those in the control group (, ; Figure 2). The result indicated that D-gal can inhibit J774A.1 macrophage proliferation.

3.3. D-gal Induced ROS Generation in J774A.1 Macrophage

ROS staining showed that the number of ROS-stained cells and the DCFH fluorescent level of the cells gradually increased with the increase in D-gal concentration (Figure 3(a)). The quantification of the DCFH fluorescence intensity showed that the intensity of DCFH fluorescence in 1.0 and 10.0 g/L D-gal groups ( and ) significantly decreased compared that in the control group (, or ; Figure 3(b)). These results indicated that D-gal can promote the ROS production in J774A.1 cell.

(a)

(b)

3.4. Effects of D-Gal on Polarity of J774A.1 Macrophages

M1 macrophages can secrete a large amount of the proinflammatory markers IL-6 and IL-12, while M2 macrophages release additional anti-inflammation marker IL-10 and have a high Arg-1 expression level. We examined the IL-6, IL-12, and IL-10 levels by ELISA and the Arg-1 mRNA expression by qPCR. Compared with the control group (IL-6: , IL-12: ), the IL-6 level was evidently higher in the 1.0 and 10.0 g/L D-gal groups ( and , , or ; Figure 4(a)), and the IL-12 level was higher in the 10.0 g/L D-gal group ( pg/mL, ; Figure 4(b)). The result suggested that D-gal can promote M1 macrophage polarization.

(a)

(b)

(c)

(d)

Figure 4

Effects of D-gal on polarity of J774A.1 macrophages. The IL-6 (a), IL-12 (b), and IL-10 (c) levels were assayed by ELISA. The results showed that the IL-6 concentrations in the 1.0 and 10.0 g/L D-gal groups were significantly higher than those in the control group (, , ). The IL-12 concentrations in the 10.0 g/L D-gal group increased compared with those in the control group (, ). The IL-10 level increased in the 0.1, 1.0, and 10.0 g/L D-gal groups compared with that in the control group (, , ). However, the IL-10 level in the 10.0 g/L D-gal group significantly decreased compared with that in the 0.1 g/L D-gal group (, ). (d) qPCR analysis of the relative expression level of Arg-1 mRNA. GAPDH was used as an internal control. The Arg-1 mRNA expression level in the 1.0 and 10.0 g/L D-gal groups was gradually lower than that in the 0.1 g/L D-gal group (, , ).

The ELISA results showed that with the increase in D-gal concentration, the IL-10 level gradually decreased in D-gal treatment groups. The IL-10 level in the 10.0 g/L D-gal group ( pg/mL) significantly decreased compared with than that in the 0.1 g/L D-gal group (, Figure 4(c)). The Arg-1 mRNA expression level also decreased in the 1.0 and 10.0 D-gal groups than that in the 0.1 g/L D-gal group (Figure 4(d)). These results indicated that M2 macrophage polarization was inhibited in the high D-gal concentration group compared with that in the low D-gal concentration group.

3.5. BB-12 Can Inhibit J774A.1 Macrophage Senescence Induced by D-Gal

As shown in Figure 5(a), after treatment with BB-12 supplement, the SA-β-gal-positive J774A.1 cells gradually decreased compared with the D-gal group. The number of SA-β-gal-positive cells in the D-gal+60 min BB-12 ( cells) and the D-gal+6 h BB-12 groups (17.4 ± 4.28/100 cells) decreased significantly compared with that in the D-gal group ( cells, , Figure 5(b)). BB-12 treatment can also remarkably reverse the induced role of D-gal on primary macrophage senescence (Figure S2). These results suggested that Bifidobacteria BB-12 can attenuate the effect of D-gal-induced macrophage senescence.

(a)

(b)

(c)

Figure 5

Effects of BB-12 on J774A.1 macrophage senescence. (a) SA-β-gal staining. Compared with the D-gal group, the SA-β-gal-positive cells in the BB-12 group significantly decreased. (b) SA-β-gal-positive cell quantification. The counts showed that the number of SA-β-gal-positive cells in the D-gal+60 min BB-12 and D-gal+6 h BB-12 groups decreased significantly compared with that in the D-gal group (, ). (c) Western blot analysis of the p53 and p16 expression levels. The p53 and p16 expression levels were gradually lower in the D-gal+30 min BB-12, D-gal+60 min BB-12, and D-gal+6 h BB-12 groups compared with those in the D-gal group. β-Actin was used as the internal control.

To investigate the effects of BB-12 on the macrophage aging induced by D-gal further, we examined p53 and p16 expression levels by Western blot. The result showed that the p53 and p16 expression levels decreased in the D-gal+30 min BB-12, D-gal+60 min BB-12, and D-gal+6 h BB-12 groups compared with that in the D-gal group (Figure 5(c)).

3.6. BB-12 Led to M1-M2 Transition of Macrophages

To explore the effects of BB-12 on the macrophage polarization, we determined the IL-6, IL-10, and IL-12 expression levels by ELISA after J774A.1 cells or primary macrophage treated by the different times of BB-12. In J774A.1 cells, we observed significantly decreased IL-6 and IL-12 expression levels in the D-gal+60 min BB-12 (IL-6: pg/mL, IL-12: pg/mL) and D-gal+6 h BB-12 groups (IL-6: pg/mL, IL-12: pg/mL) compared with that in the D-gal group (IL-6 : pg/mL, IL-12: pg/mL, or ; Figures 6(a) and 6(b)). By contrast, the IL-10 level remarkably increased in the D-gal+60 min BB-12 ( pg/mL) and D-gal+6 h BB-12 groups ( pg/mL) compared with that in the D-gal group ( pg/mL, ; Figure 6(c)). Similar ELISA results were also observed in primary macrophage treated with BB-12 (Figure S3). The Arg-1 mRNA expression level of J774A.1 cells in the D-gal+60 min and D-gal+6 h groups was also higher than that in the D-gal group (, Figure 6(d)). These results proved that BB-12 can lead to a shift in macrophage cells from the M1-polarized state to M2-polarized state.

(a)

(b)

(c)

(d)

Figure 6

Effects of BB-12 on J774A.1 macrophage polarization. The production of IL-6 (a), IL-12 (b), and IL-10 (c) was assayed by ELISA. The results showed that the IL-6 and IL-12 levels in the D-gal+60 min and D-gal+6 h groups decreased compared with that in the D-gal group ( or , ). IL-10 in the D-gal+60 min and D-gal+6 h groups was significantly higher than that in the D-gal group (, ). (d) qPCR analysis of the relative expression level of Arg-1 mRNA. GAPDH was used as an internal control. The Arg-1 mRNA expression level in D-gal+60 min and D-gal+6 h groups increased compared with that in the D-gal group (, ).

3.7. BB-12 Promoted p-STAT6 Expression Level in J774A.1 Macrophage

STAT1 and STAT6 were the key-mediated factors of M1 and M2 macrophage polarity, and the Western blot results showed that the p-STAT1 expression and p-STAT1/STAT1 ratios in the BB-12 treatment group decreased compared with those in the D-gal group. With the prolongation of the BB-12 treatment time, the p-STAT6 expression level and p-STAT6/STAT6 ratios significantly increased in the BB-12 treatment groups compared with those in the D-gal group (Figures 7(a)–7(c)). This result further suggested that Bifidobacteria BB-12 can promote the macrophage M2-polarized change, and the STAT6 may be the main mediated factor.

(a)

(b)

(c)

Figure 7

Effects of BB-12 on STAT1 and STAT6 expression levels. (a) Western blot analysis of p-STAT1, STAT1, p-STAT6, and STAT6 protein expression levels. p-STAT1 expression decreased in the group after treatment with BB-12 compared with that in D-gal group. However, with the increase in BB-12 treatment time, the p-STAT6 expression levels were gradually higher in the D-gal+30 min BB-12, D-gal+60 min BB-12, and D-gal+6 h BB-12 groups compared with those in the D-gal group. β-Actin was used as the internal control. (b) p-STAT1/STAT1 ratios and (c) p-STAT6/STAT6 ratios. or vs. the D-gal group; .

4. Discussion

Immunosenescence, which is an important change in the aging of organism, facilitates the genesis and development of age-related diseases, such as Alzheimer’s disease [41] and tumor [42]. Immune cell aging is the basic change in immunosenescence, which is specifically manifested by the declining quantity of immune cells, damaged immunoreaction capacity, and weakened intercellular coordination ability [43, 44]. The researchers found that macrophages can also experience change due to aging with organism aging [45]. Oxidative stress level in senescent macrophages is significantly increased compared with that in young macrophages, thereby indicating that ROS is one of factors facilitating macrophage aging [46]. According to our previous research [9, 10], D-gal, which is a ROS promoter, was first used to induce macrophage aging in vitro. As D-gal concentration increases, the quantity of SA-β-gal-stained-positive J774A.1 macrophages gradually increased, the expression levels of aging-related proteins p53 and p16 increased, the cell proliferation ability was weakened, and the intracellular ROS level gradually increased. These results indicated that D-gal can induce macrophage aging. The 1.0 and 10.0 g/L groups had evident facilitating effects on macrophage aging.

The two dominant states of macrophage activation were described as follows: M1 or M2 under different environmental stimulation conditions [47]. Aging macrophage can shift differently from anti-inflammatory M2 into proinflammatory M1. In aging mice, the expression levels of the M1 macrophage markers CD68, tumor necrosis factor-α, and IL-6 increased, and those of the M2 macrophage markers CD36 and IL-10 decreased [6]. However, the inhibition of cellular senescence can facilitate macrophage differentiation into M2 state and upregulate the expression levels of the M2 macrophage markers, such as Arg-1 [7], MRC1, and AMAC1 [8]. In the present study, with the increase in macrophage aging degree, the secreted amounts of the M1 markers IL-6 and IL-12 gradually increased, while the M2 marker IL-10 and Arg-1 mRNA levels gradually decreased. These results showed that aging macrophage can be differentiated into proinflammatory M1 type, which exerted an important effect on inflamm-aging.

Bifidobacterium is an important intestinal probiotic [48, 49]. The recent study indicated that Bifidobacterium can significantly increase the longevity of Caenorhabditis elegans [50, 51]. The present study showed for the first time that Bifidobacterium BB-12 can considerably delay J774A.1 macrophage aging. As the treatment time passed by, the quantity of SA-β-gal-positive cells in the BB-12 treatment group gradually reduced, and expression levels of the aging-related proteins p53 and p16 decreased. Thus, BB-12 had an evident protective effect on D-gal-induced macrophage aging. Further polarity detection results showed that BB-12 supernatant treatment can reverse the inductive effect of D-gal on macrophage M1 polarization and promote the expression of J774A.1 macrophage M2 polarization marker IL-10 and Arg-1. STAT1 and STAT6 are the key molecules mediating polar differentiation of macrophages M1 and M2 [52, 53] and closely related to immunosenescence [54, 55]. To confirm the influence of Bifidobacterium on M1 and M2 polarization further, we further detected the influences of BB-12 on STAT1 and STAT6. As the BB-12 treatment time continued, p-STAT1 expression gradually reduced, while p-STAT6 expression gradually increased. The results further verified that BB-12 can inhibit the differentiation of macrophages into M1 type and facilitate M2 macrophage polarization, thereby indicating that BB-12 can resist inflammatory aging. Burns et al. [56] also found that BB-12 can relieve colonic inflammatory state in mice, which was consistent with the experimental results in the present study.

5. Conclusion

The results of this study showed that D-gal can induce J774A.1 macrophage aging, increase the expression levels of aging-related proteins p53 and p16, and facilitate J774A.1 macrophage polarization into M1 type by promoting ROS generation. Bifidobacterium BB-12 can reverse the inductive effect of D-gal on J774A.1 macrophage aging and result in J774A.1 macrophage polarization into M2 type by promoting p-STAT6 expression. This result indicated that Bifidobacterium can delay immunosenescence and inflamm-aging. The effective constituents of Bifidobacterium, which regulates macrophage aging and their molecular mechanism, should be further studied and explored.

Data Availability

The data used to support the findings of this study are available from the corresponding author upon request.

Conflicts of Interest

The authors declare no conflict of interest.

Authors’ Contributions

D.-Y.Z. and J.-P.P. conceived and designed the experiments. Z.-Y.P., X.-K.Y., Y.-F.C., C.-H.G., and Y.-T.Y. performed the experiments. D.-Y.Z., X.-F.J., and N.L. analyzed the data. D.-Y.Z., Z.-Y.P., and X.-K. Y. wrote the paper.

Acknowledgments

The authors gratefully acknowledge the financial supports from the Natural Science Foundation of Zhejiang Province (grant no. LY17H250001); the National Natural Science Foundation of China (grant no. 81671613); the Science Research Foundation of Zhejiang Health Bureau (grant no. 2016KYB024); the Traditional Chinese Medicine Science and Technology Project of Zhejiang Province (grant no. 2016ZA024); the Basic Public Welfare Research Project in Zhejiang Province (grant no. LGD19C070001); the Scientific and Technological Developing Scheme of Hangzhou (grant no. 20180533B30); and the Opening Foundation of the State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, the First Affiliated Hospital of Medical College, Zhejiang University (grant no. 2017KF09) and the 17th International Congress of Immunology (Beijing, 2019) for the presentation of our work abstract and the academic discussion of the conference scholars.

Supplementary Materials

Supplementary Figure 1: the results of SA-β-gal staining showed that D-gal can induce peritoneal macrophage senescence. Supplementary Figure 2: the results of SA-β-gal staining showed that BB-12 treatment can remarkably reverse the induced role of D-gal on peritoneal macrophage senescence. Supplementary Figure 3: BB-12 can lead to a shift in peritoneal macrophage cells from the M1-polarized state to the M2-polarized state. (Supplementary Materials)

References

Y. H. Youm, T. L. Horvath, D. J. Mangelsdorf, S. A. Kliewer, and V. D. Dixit, “Prolongevity hormone FGF21 protects against immune senescence by delaying age-related thymic involution,” Proceedings of the National Academy of Sciences of the United States of America, vol. 113, no. 4, pp. 1026–1031, 2016.
View at: Publisher Site | Google Scholar
C. Solana, R. Tarazona, and R. Solana, “Immunosenescence of natural killer cells, inflammation, and Alzheimer’s disease,” International Journal of Alzheimer's Disease, vol. 2018, article 3128758, 9 pages, 2018.
View at: Publisher Site | Google Scholar
A. A. Sadighi Akha, “Aging and the immune system: an overview,” Journal of Immunological Methods, vol. 463, pp. 21–26, 2018.
View at: Publisher Site | Google Scholar
X. Xu, J. Xu, J. Wu et al., “Phosphorylation-mediated IFN-γR2 membrane translocation is required to activate macrophage innate response,” Cell, vol. 175, no. 5, pp. 1336–1351.e17, 2018.
View at: Publisher Site | Google Scholar
H. Li, Y. F. Luo, Y. S. Wang et al., “Using ROS as a second messenger, NADPH oxidase 2 mediates macrophage senescence via interaction with NF-κB during Pseudomonas aeruginosa infection,” Oxidative Medicine and Cellular Longevity, vol. 2018, Article ID 9741838, 10 pages, 2018.
View at: Publisher Site | Google Scholar
V. Karuppagounder, V. V. Giridharan, S. Arumugam et al., “Modulation of macrophage polarization and HMGB1-TLR2/TLR4 cascade plays a crucial role for cardiac remodeling in senescence-accelerated prone mice,” PLoS One, vol. 11, no. 4, article e0152922, 2016.
View at: Publisher Site | Google Scholar
C. Cudejko, K. Wouters, L. Fuentes et al., “p16INK4a deficiency promotes IL-4-induced polarization and inhibits proinflammatory signaling in macrophages,” Blood, vol. 118, no. 9, pp. 2556–2566, 2011.
View at: Publisher Site | Google Scholar
L. Fuentes, K. Wouters, S. A. Hannou et al., “Downregulation of the tumour suppressor p16INK4A contributes to the polarisation of human macrophages toward an adipose tissue macrophage (ATM)-like phenotype,” Diabetologia, vol. 54, no. 12, pp. 3150–3156, 2011.
View at: Publisher Site | Google Scholar
D. Zhang, B. Yan, S. Yu et al., “Coenzyme Q10 inhibits the aging of mesenchymal stem cells induced by D-galactose through Akt/mTOR signaling,” Oxidative Medicine and Cellular Longevity, vol. 2015, Article ID 867293, 10 pages, 2015.
View at: Publisher Site | Google Scholar
B. Yan, S. Yu, X. Feng et al., “Effects of D-galactose on ageing of rat mesenchymal stem cells,” Zhejiang Da Xue Xue Bao Yi Xue Ban, vol. 42, no. 6, pp. 625–631, 2013.
View at: Google Scholar
Y. Xu, Y. Li, L. Ma et al., “d-galactose induces premature senescence of lens epithelial cells by disturbing autophagy flux and mitochondrial functions,” Toxicology Letters, vol. 289, pp. 99–106, 2018.
View at: Publisher Site | Google Scholar
F. Turroni, S. Duranti, F. Bottacini, S. Guglielmetti, D. Van Sinderen, and M. Ventura, “Bifidobacterium bifidum as an example of a specialized human gut commensal,” Frontiers in Microbiology, vol. 5, p. 437, 2014.
View at: Publisher Site | Google Scholar
M. J. Hopkins, R. Sharp, and G. T. Macfarlane, “Age and disease related changes in intestinal bacterial populations assessed by cell culture, 16S rRNA abundance, and community cellular fatty acid profiles,” Gut, vol. 48, no. 2, pp. 198–205, 2001.
View at: Publisher Site | Google Scholar
V. Lesniewska, I. Rowland, P. D. Cani, A. M. Neyrinck, N. M. Delzenne, and P. J. Naughton, “Effect on components of the intestinal microflora and plasma neuropeptide levels of feeding Lactobacillus delbrueckii, Bifidobacterium lactis, and inulin to adult and elderly rats,” Applied and Environmental Microbiology, vol. 72, no. 10, pp. 6533–6538, 2006.
View at: Publisher Site | Google Scholar
T. Odamaki, K. Kato, H. Sugahara et al., “Age-related changes in gut microbiota composition from newborn to centenarian: a cross-sectional study,” BMC Microbiology, vol. 16, p. 90, 2016.
View at: Publisher Site | Google Scholar
F. Wang, G. Huang, D. Cai et al., “Qualitative and semiquantitative analysis of fecal Bifidobacterium species in centenarians living in Bama, Guangxi, China,” Current Microbiology, vol. 71, no. 1, pp. 143–149, 2015.
View at: Publisher Site | Google Scholar
Z. J. Yi, Y. R. Fu, M. Li, K. S. Gao, and X. G. Zhang, “Effect of LTA isolated from bifidobacteria on D-galactose-induced aging,” Experimental Gerontology, vol. 44, no. 12, pp. 760–765, 2009.
View at: Publisher Site | Google Scholar
M. Jungersen, A. Wind, E. Johansen, J. E. Christensen, B. Stuer-Lauridsen, and D. Eskesen, “The science behind the probiotic strain Bifidobacterium animalis subsp. lactis BB-12(®),” Microorganisms, vol. 2, no. 2, pp. 92–110, 2014.
View at: Publisher Site | Google Scholar
E. Brasili, E. Mengheri, A. Tomassini et al., “Lactobacillus acidophilus La5 and Bifidobacterium lactis Bb12 induce different age-related metabolic profiles revealed by 1H-NMR spectroscopy in urine and feces of mice,” The Journal of Nutrition, vol. 143, no. 10, pp. 1549–1557, 2013.
View at: Publisher Site | Google Scholar
M. Arenas-Padilla, J. L. Duarte-Gutierrez, and V. Mata-Haro, “Bifidobacterium animalis ssp. lactisBb12 induces IL-10 through cell membrane-associated components via TLR2 in swine,” Journal of Applied Microbiology, vol. 125, no. 6, pp. 1881–1889, 2018.
View at: Publisher Site | Google Scholar
M. Matsumoto, K. Hara, and Y. Benno, “The influence of the immunostimulation by bacterial cell components derived from altered large intestinal microbiota on probiotic anti-inflammatory benefits,” FEMS Immunology and Medical Microbiology, vol. 49, no. 3, pp. 387–390, 2007.
View at: Publisher Site | Google Scholar
A. Sheikhi, M. Shakerian, H. Giti et al., “Probiotic yogurt culture Bifidobacterium animalis subsp. lactis BB-12 and Lactobacillus acidophilus LA-5 modulate the cytokine secretion by peripheral blood mononuclear cells from patients with ulcerative colitis,” Drug Research, vol. 66, no. 6, pp. 300–305, 2016.
View at: Publisher Site | Google Scholar
D. J. Merenstein, T. P. Tan, A. Molokin et al., “Safety of Bifidobacterium animalis subsp. lactis (B. lactis) strain BB-12-supplemented yogurt in healthy adults on antibiotics: a phase I safety study,” Gut Microbes, vol. 6, no. 1, pp. 66–77, 2015.
View at: Publisher Site | Google Scholar
R. Xu, N. Shang, and P. Li, “In vitro and in vivo antioxidant activity of exopolysaccharide fractions from Bifidobacterium animalis RH,” Anaerobe, vol. 17, no. 5, pp. 226–231, 2011.
View at: Publisher Site | Google Scholar
C. Hoarau, C. Lagaraine, L. Martin, F. Velge-Roussel, and Y. Lebranchu, “Supernatant of Bifidobacterium breve induces dendritic cell maturation, activation, and survival through a Toll-like receptor 2 pathway,” The Journal of Allergy and Clinical Immunology, vol. 117, no. 3, pp. 696–702, 2006.
View at: Publisher Site | Google Scholar
B. Yang, H. Chen, C. Stanton, Y. Q. Chen, H. Zhang, and W. Chen, “Mining bifidobacteria from the neonatal gastrointestinal tract for conjugated linolenic acid production,” Bioengineered, vol. 8, no. 3, pp. 232–238, 2017.
View at: Publisher Site | Google Scholar
M. Bermudez-Brito, S. Munoz-Quezada, C. Gomez-Llorente et al., “Cell-free culture supernatant of Bifidobacterium breve CNCM I-4035 decreases pro-inflammatory cytokines in human dendritic cells challenged with Salmonella typhi through TLR activation,” PLoS One, vol. 8, no. 3, article e59370, 2013.
View at: Publisher Site | Google Scholar
H. Suido and M. Miyao, “Bifidobacterium longum-fermented broccoli supernatant inhibited the growth of Candida albicans and some pathogenic bacteria in vitro,” Biocontrol Science, vol. 13, no. 2, pp. 41–48, 2008.
View at: Publisher Site | Google Scholar
W. Ting, “Experimental research on Bifidobacterium-cultivated supernatant fluid regulating blood fat index of aging rats underlined by D-gal,” Chinese Journal of Microecology, vol. 2, 2008.
View at: Google Scholar
S. K. Biswas and A. Mantovani, “Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm,” Nature Immunology, vol. 11, no. 10, pp. 889–896, 2010.
View at: Publisher Site | Google Scholar
A. Shapouri-Moghaddam, S. Mohammadian, H. Vazini et al., “Macrophage plasticity, polarization, and function in health and disease,” Journal of Cellular Physiology, vol. 233, no. 9, pp. 6425–6440, 2018.
View at: Publisher Site | Google Scholar
P. Kumar, R. Tyagi, G. Das, and S. Bhaskar, “Mycobacterium indicus pranii and Mycobacterium bovis BCG lead to differential macrophage activation in Toll-like receptor-dependent manner,” Immunology, vol. 143, no. 2, pp. 258–268, 2014.
View at: Publisher Site | Google Scholar
D. Ruffell, F. Mourkioti, A. Gambardella et al., “A CREB-C/EBPbeta cascade induces M2 macrophage-specific gene expression and promotes muscle injury repair,” Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 41, pp. 17475–17480, 2009.
View at: Publisher Site | Google Scholar
B. Zhang, W. M. Bailey, K. J. Braun, and J. C. Gensel, “Age decreases macrophage IL-10 expression: implications for functional recovery and tissue repair in spinal cord injury,” Experimental Neurology, vol. 273, pp. 83–91, 2015.
View at: Publisher Site | Google Scholar
N. Ding, Y. Wang, C. Dou et al., “Physalin D regulates macrophage M1/M2 polarization via the STAT1/6 pathway,” Journal of Cellular Physiology, vol. 234, no. 6, pp. 8788–8796, 2019.
View at: Publisher Site | Google Scholar
H. Guo, Z. Mi, D. E. Bowles, S. D. Bhattacharya, and P. C. Kuo, “Osteopontin and protein kinase C regulate PDLIM2 activation and STAT1 ubiquitination in LPS-treated murine macrophages,” The Journal of Biological Chemistry, vol. 285, no. 48, pp. 37787–37796, 2010.
View at: Publisher Site | Google Scholar
M. A. Bouhlel, B. Derudas, E. Rigamonti et al., “PPARγ activation primes human monocytes into alternative M2 macrophages with anti-inflammatory properties,” Cell Metabolism, vol. 6, no. 2, pp. 137–143, 2007.
View at: Publisher Site | Google Scholar
S. Rangaraju, E. B. Dammer, S. A. Raza et al., “Identification and therapeutic modulation of a pro-inflammatory subset of disease-associated-microglia in Alzheimer’s disease,” Molecular Neurodegeneration, vol. 13, no. 1, p. 24, 2018.
View at: Publisher Site | Google Scholar
R. Uhlemann, K. Gertz, W. Boehmerle et al., “Actin dynamics shape microglia effector functions,” Brain Structure & Function, vol. 221, no. 5, pp. 2717–2734, 2016.
View at: Publisher Site | Google Scholar
D. Y. Zhang, H. J. Wang, and Y. Z. Tan, “Wnt/β-catenin signaling induces the aging of mesenchymal stem cells through the DNA damage response and the p53/p21 pathway,” PLoS One, vol. 6, no. 6, article e21397, 2011.
View at: Publisher Site | Google Scholar
A. Tramutola, G. Abate, C. Lanzillotta et al., “Protein nitration profile of CD3⁺ lymphocytes from Alzheimer disease patients: novel hints on immunosenescence and biomarker detection,” Free Radical Biology & Medicine, vol. 129, pp. 430–439, 2018.
View at: Publisher Site | Google Scholar
G. Pawelec, “Immunosenescence and cancer,” Biogerontology, vol. 18, no. 4, pp. 717–721, 2017.
View at: Publisher Site | Google Scholar
S. Palmer, L. Albergante, C. C. Blackburn, and T. J. Newman, “Thymic involution and rising disease incidence with age,” Proceedings of the National Academy of Sciences of the United States of America, vol. 115, no. 8, pp. 1883–1888, 2018.
View at: Publisher Site | Google Scholar
R. Vicente, A. L. Mausset-Bonnefont, C. Jorgensen, P. Louis-Plence, and J. M. Brondello, “Cellular senescence impact on immune cell fate and function,” Aging Cell, vol. 15, no. 3, pp. 400–406, 2016.
View at: Publisher Site | Google Scholar
B. M. Hall, V. Balan, A. S. Gleiberman et al., “Aging of mice is associated with p16(Ink4a)- and β-galactosidase-positive macrophage accumulation that can be induced in young mice by senescent cells,” Aging, vol. 8, no. 7, pp. 1294–1315, 2016.
View at: Publisher Site | Google Scholar
M. de la Fuente, A. Hernanz, N. Guayerbas, P. Alvarez, and C. Alvarado, “Changes with age in peritoneal macrophage functions. Implication of leukocytes in the oxidative stress of senescence,” Cellular and Molecular Biology, vol. 50, 2004.
View at: Google Scholar
C. Atri, F. Guerfali, and D. Laouini, “Role of human macrophage polarization in inflammation during infectious diseases,” International Journal of Molecular Sciences, vol. 19, no. 6, p. 1801, 2018.
View at: Publisher Site | Google Scholar
E. Barba-Vidal, L. Castillejos, P. López-Colom, M. Rivero Urgell, J. A. Moreno Muñoz, and S. M. Martín-Orúe, “Evaluation of the probiotic strain Bifidobacterium longum subsp. infantis CECT 7210 capacities to improve health status and fight digestive pathogens in a piglet model,” Frontiers in Microbiology, vol. 8, p. 533, 2017.
View at: Publisher Site | Google Scholar
N. Castro-Bravo, J. M. Wells, A. Margolles, and P. Ruas-Madiedo, “Interactions of surface exopolysaccharides from Bifidobacterium and Lactobacillus within the intestinal environment,” Frontiers in Microbiology, vol. 9, p. 2426, 2018.
View at: Publisher Site | Google Scholar
L. Zhao, Y. Zhao, R. Liu et al., “The transcription factor DAF-16 is essential for increased longevity in C. elegans exposed to Bifidobacterium longum BB68,” Scientific Reports, vol. 7, no. 1, article 7974, p. 7408, 2017.
View at: Publisher Site | Google Scholar
T. Sugawara and K. Sakamoto, “Killed Bifidobacterium longum enhanced stress tolerance and prolonged life span of Caenorhabditis elegans via DAF-16,” The British Journal of Nutrition, vol. 120, no. 8, pp. 872–880, 2018.
View at: Publisher Site | Google Scholar
H. Iwata, C. Goettsch, A. Sharma et al., “PARP9 and PARP14 cross-regulate macrophage activation via STAT1 ADP-ribosylation,” Nature Communications, vol. 7, no. 1, article 12849, 2016.
View at: Publisher Site | Google Scholar
S. Chen, Z. Lu, F. Wang, and Y. Wang, “Cathelicidin-WA polarizes E. coli K88-induced M1 macrophage to M2-like macrophage in RAW264.7 cells,” International Immunopharmacology, vol. 54, pp. 52–59, 2018.
View at: Publisher Site | Google Scholar
M. Holcar, A. Goropevsek, A. Ihan, and T. Avcin, “Age-related differences in percentages of regulatory and effector T lymphocytes and their subsets in healthy individuals and characteristic STAT1/STAT5 signalling response in helper T lymphocytes,” Journal of Immunology Research, vol. 2015, Article ID 352934, 13 pages, 2015.
View at: Publisher Site | Google Scholar
A. Hasegawa, T. Miki, H. Hosokawa et al., “Impaired GATA3-dependent chromatin remodeling and Th2 cell differentiation leading to attenuated allergic airway inflammation in aging mice,” Journal of Immunology, vol. 176, no. 4, pp. 2546–2554, 2006.
View at: Publisher Site | Google Scholar
P. Burns, J. Alard, J. Hrdy et al., “Spray-drying process preserves the protective capacity of a breast milk-derived Bifidobacterium lactis strain on acute and chronic colitis in mice,” Scientific Reports, vol. 7, p. 43211, 2017.
View at: Publisher Site | Google Scholar

Copyright

Copyright © 2019 Da-yong Zhang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

PDF Download Citation

Download other formats

Order printed copies

Views

1254

Downloads

1244

Citations